SCHEMBL407961

SCHEMBL407961

CCCCCCCCCCCCC=CCC(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.70
PPARD Q03181 5/20 0.70
PPARA Q07869 5/20 0.70
F7 P08709 5/20 0.70
F3 P13726 5/20 0.70
TERT O14746 3/20 0.70
PTPN1 P18031 3/20 0.70
TOP1 P11387 3/20 0.70
HSD17B10 Q99714 3/20 0.70
FABP4 P15090 3/20 0.70
MAPT P10636 2/20 0.70
BLM P54132 2/20 0.70
LMNA P02545 2/20 0.70
ALOX15 P16050 2/20 0.70
DUSP3 P51452 2/20 0.70
CYP19A1 P11511 2/20 0.70
PTGS1 P23219 2/20 0.70
NR4A2 P43354 2/20 0.70
SIRT6 Q8N6T7 2/20 0.70
PTPN7 P35236 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17164560 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL1302089 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL2573402 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL2554324 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL8749060 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL2576033 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL2574511 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL6415162 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL995105 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3
SCHEMBL2571672 1.00 PPARG (0.70) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919941-B2 Functional lipid constructs KODE BIOTECH LIMITED (NZ) 2021-02-16 US claimed
US-20170218027-A1 FUNCTIONAL LIPID CONSTRUCTS KODE BIOTECH LIMITED (NZ) 2017-08-03 US claimed
US-20170082642-A1 FLUORESCENT CELL MARKERS KODE BIOTECH LTD (NZ) 2017-03-23 US claimed
US-20160361423-A1 CARBOHYDRATE-LIPID CONSTRUCTS AND THEIR USE IN PREVENTING OR TREATING VIRAL INFECTION KODE BIOTECH LTD (NZ) 2016-12-15 US claimed
EP-2201025-B1 FUNCTIONAL LIPID CONSTRUCTS KODE BIOTECH LTD (NZ) 2016-04-20 EP claimed
EP-2069460-B1 FLUORESCENT CELL MARKERS KODE BIOTECH LTD (NZ) 2013-10-16 EP claimed
US-20120021430-A1 FUNCTIONAL LIPID CONSTRUCTS KODE BIOTECH LIMITED (NZ) 2012-01-26 US claimed
WO-2010143983-A1 ASSAYS FOR SEROLOGICAL DETECTION OF SYPHILIS KODE BIOTECH LIMITED (NZ) 2010-12-16 WO claimed
US-20100227402-A1 Cell Surface Coating with Hyaluronic Acid Oligomer Derivative KODE BIOTECH LIMITED (NZ) 2010-09-09 US claimed
US-20100203637-A1 Fluorescent cell markers KODE BIOTECH LIMITED (NZ) 2010-08-12 US claimed
US-20070197466-A1 Synthetic membrane anchors KODE BIOTECH LIMITED (NZ) 2007-08-23 US claimed
WO-2007035116-A1 CELL SURFACE COATING WITH HYALURONIC ACID OLIGOMER DERIVATIVE KODE BIOTECH LIMITED (NZ) 2007-03-29 WO claimed
EP-1735323-A1 SYNTHETIC MEMBRANE ANCHORS Kiwi Ingenuity Limited (NZ) 2006-12-27 EP claimed
WO-2005090368-A1 SYNTHETIC MEMBRANE ANCHORS KIWI INGENUITY LIMITED (NZ) 2005-09-29 WO claimed
EP-1051069-B1 DEVICE FOR LURING AND CATCHING INSECTS LOHMANN THERAPIE SYST LTS (DE) 2003-04-02 EP claimed
EP-1051069-A1 DEVICE FOR LURING AND CATCHING INSECTS LTS LOHMANN Therapie-Systeme GmbH (DE) 2000-11-15 EP claimed
WO-1999037146-A1 DEVICE FOR LURING AND CATCHING INSECTS LTS LOHMANN THERAPIE-SYSTEME AG (DE) 1999-07-29 WO claimed
US-5085934-A Support, matrix resin and lower molecular weight components of fatty acid and aliphatic saturated dicarboxylic acid dispersed RICOH COMPANY, LTD. (JP) 1992-02-04 US claimed
US-4977030-A FORMING IMAGE OR ERASING DEPENDENT ON TEMPERATURE RICOH CO., LTD. (JP) 1990-12-11 US claimed
US-4917948-A MATRIX RESIN, MONOCARBOXYLIC FATTY ACID AND DICARBOXYLIC ACID OR DERIVATIVE THEREOF RICOH COMPANY, LTD. (JP) 1990-04-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170082642-A1 FLUORESCENT CELL MARKERS PTDSS2, SPTLC2, CD69 PPARG 4163/4885PPARD 3972/4885PPARA 3791/4885
US-20160361423-A1 CARBOHYDRATE-LIPID CONSTRUCTS AND THEIR USE IN PREVENTING OR TREATING VIRAL INFECTION HAVCR2, SIGLEC7, FUT5 PPARG 2194/4885PPARD 1798/4885PPARA 1420/4885
US-20170218027-A1 FUNCTIONAL LIPID CONSTRUCTS CETP, LCAT, LIPA PPARG 2921/4885PPARD 3136/4885PPARA 2635/4885
US-20070197466-A1 Synthetic membrane anchors LY96, GOLIM4, PTDSS2 PPARG 2353/4885PPARD 2198/4885PPARA 2473/4885
US-10919941-B2 Functional lipid constructs CETP, LCAT, LIPA PPARG 2921/4885PPARD 3136/4885PPARA 2635/4885
US-20100203637-A1 Fluorescent cell markers SPTLC2, CD69, PTDSS2 PPARG 3944/4885PPARD 3712/4885PPARA 3534/4885
US-20100227402-A1 Cell Surface Coating with Hyaluronic Acid Oligomer Derivative CD44, EPCAM, ACR PPARG 2123/4885PPARD 2258/4885PPARA 1428/4885
US-20120021430-A1 FUNCTIONAL LIPID CONSTRUCTS CETP, LCAT, SGMS1 PPARG 2729/4885PPARD 2632/4885PPARA 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.